Institute for Regenerative Medicine & Biotherapy
- World rank, all time
- #18,801 of 42,892
- Rank in France
- #1,206 of 2,321
- Research works
- 185 ▲ 18% vs 2013–17
- Citations
- 5.8k 31.6 per fractional work
- Top-10% rate
- 16.9% record average 16.5%
- Open access
- 57% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 14.1×. Every wedge is a field page.
- Immunology and Microbiology 14.1×
- Biochemistry, Genetics and Molecular Biology 3.4×
- Medicine 2.9×
- Neuroscience 1.1×
- Dentistry 0.9×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Chemistry 0.6×
- Nursing 0.6×
- Health Professions 0.5×
- Materials Science 0.4×
- Veterinary 0.3×
- Decision Sciences 0.3×
- Agricultural and Biological Sciences 0.2×
- Engineering 0.2×
- Environmental Science 0.1×
- Mathematics 0.1×
- Economics, Econometrics and Finance 0.1×
- Physics and Astronomy 0.1×
- Psychology 0.1×
- Social Sciences 0.0×
Which keywords describe research at Institute for Regenerative Medicine & Biotherapy?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Immunity, Cancer, Regenerative Medicine, Epidemiology, Extracellular Matrix, Mesenchymal Stem Cells and Regeneration.
- Stem Cell Therapy
- Multipotent
- Immunomodulation
- Bronchopulmonary Dysplasia
- Isolation
- Antiretroviral Therapy
- Stromal Cells
- Immunosuppressive Therapy
- Angiogenesis
- Mutation
- Cancer Immunotherapy
- ACE2 Receptor
- Reactive Oxygen Species
- Autoantibodies
- Differentiation
- Vaccine
- Mesenchymal Stem Cells
- Treatment
- Immunity
- Epidemiology
- Inflammation
- Cancer
- Regenerative Medicine
- Extracellular Matrix
- Regeneration
- Viral Transmission
- Immunotherapy
- Genetic Mutations
- Thrombosis
- Autoimmunity
- Lymphoma
- SARS-CoV-2
- Coronavirus
- Leukemia
- spike protein
- HIV
- Preterm Infants
- Immune Dysregulation
- Matrix Metalloproteinases
- Primary Immunodeficiency
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation8▲ 6.6×37 topics
- Epidemiology5▲ 2.2×30 topics
- Cancer4▲ 5.5×25 topics
- Immunity4▲ 18×7 topics
- Regenerative Medicine3▲ 19×5 topics
- Treatment3▲ 4.0×13 topics
- Extracellular Matrix2▲ 25×3 topics
- Mesenchymal Stem Cells2▲ 39×3 topics
- Regeneration2▲ 21×2 topics
- Vaccine2▲ 9.6×5 topics
- Viral Transmission2▲ 25×3 topics
- Differentiation2▲ 60×2 topics
- Immunotherapy2▲ 4.7×9 topics
- Autoantibodies2▲ 14×6 topics
- Genetic Mutations2▲ 7.7×11 topics
- Reactive Oxygen Species2▲ 8.1×4 topics
- Thrombosis2▲ 11×6 topics
- ACE2 Receptor2▲ 13×3 topics
- Autoimmunity2▲ 21×4 topics
- Cancer Immunotherapy2▲ 19×3 topics
- Lymphoma2▲ 19×3 topics
- Mutation2▲ 16×3 topics
- SARS-CoV-22▲ 9.1×3 topics
- Angiogenesis2▲ 8.4×9 topics
- Coronavirus2▲ 13×1 topic
- Immunosuppressive Therapy2▲ 14×4 topics
- Leukemia2▲ 32×2 topics
- Stromal Cells2▲ 34×2 topics
- spike protein2▲ 26×1 topic
- Antiretroviral Therapy1▲ 16×3 topics
- HIV1▲ 30×2 topics
- Isolation1▲ 44×2 topics
- Preterm Infants1▲ 21×3 topics
- Bronchopulmonary Dysplasia1▲ 36×1 topic
- Immune Dysregulation1▲ 30×1 topic
- Immunomodulation1▲ 19×1 topic
- Matrix Metalloproteinases1▲ 17×2 topics
- Multipotent1▲ 69×1 topic
- Primary Immunodeficiency1▲ 79×1 topic
- Stem Cell Therapy1▲ 27×2 topics
Which research topics does Institute for Regenerative Medicine & Biotherapy publish most on?
By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Neonatal Respiratory Health Research, Neutrophil, Myeloperoxidase and Oxidative Mechanisms and Tissue Engineering and Regenerative Medicine.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
- 2 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 1 works
- 3 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 1 works
- 4 Tissue Engineering and Regenerative Medicine Surgery 1 works
- 5 Mesenchymal stem cell research Genetics 1 works
- 6 Immunodeficiency and Autoimmune Disorders Immunology 1 works
- 7 Respiratory viral infections research Epidemiology 1 works
- 8 Cell Adhesion Molecules Research Immunology and Allergy 1 works
- 9 CAR-T cell therapy research Oncology 1 works
- 10 Pneumocystis jirovecii pneumonia detection and treatment Epidemiology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institute for Regenerative Medicine & Biotherapy's research output changed?
Output in 2018–2022 was 18% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Montpellier
- Université de Montpellier
- Université Paul-Valéry Montpellier
- Centre Hospitalier Universitaire de Montpellier
- Laboratoire d'Informatique, de Robotique et de Microélectronique de Montpellier
- Hôpital Lapeyronie
- École Nationale Supérieure de Chimie de Montpellier
- Hôpital Saint Eloi
- Hôpital Arnaud de Villeneuve
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.